Cha Joo Young Takes Temporary Hiatus to Recover from Nosebleed Surgery

Thread
Cha Joo Young

Cha Joo Young

Last updated:

Actress Cha Joo Young, known for her compelling villain performance in the Netflix hit The Glory, will temporarily step away from official activities to focus on her health. On January 25, 2026, her agency, Ghost Studio, confirmed that she will be unable to attend previously scheduled events and promotional activities due to medical reasons.

Cha Joo Young has been experiencing long-term, recurring epistaxis (nosebleeds), and after thorough medical examinations, her doctors advised that an otolaryngology (ENT) procedure could no longer be postponed. She has now undergone the surgery and is currently in the recovery and observation stage, making it difficult for her to participate in official schedules during this period.

Cha Joo Young
Cha Joo Young

Cha Joo Young’s Agency Ensures Full Support During Recovery, Promises Eventual Return

Ghost Studio issued a statement apologizing on behalf of the actress and asked for public understanding regarding her temporary absence. The agency emphasized that they will fully support Cha Joo Young’s recovery and assured fans that she will return to her projects and public appearances once she has received adequate treatment and regained her health.

The announcement has highlighted Cha Joo Young’s commitment to following medical guidance while prioritizing her well-being. Fans and colleagues have expressed their support and best wishes for her swift and complete recovery. Her temporary hiatus reflects a careful approach to health management, ensuring that she can return to her work safely and continue her career in full strength.

Written by Mason Turner Senior Editor Kpop, Content, Strategy, Trends, Fandom, Reviews, Publishing Mason Turner has 8 years of experience in editorial management and holds a degree in Communications with certification in digital publishing and workflow optimization.

Mason Turner manages K-pop editorial output with an emphasis on structure, consistency, and publication efficiency. He refines content pipelines, ensuring articles meet accuracy and formatting standards before release. His approach integrates editorial judgment with performance data to maintain relevance across topics. He focuses on scalable processes that support high volume publishing without compromising quality.

THREAD

Share your take. All comments are held for review before appearing.

Be the first to share your thoughts.